Ricci-Junior, E., Rosa, A. S., Nascimento, T. d., Santos-Oliveira, R., Silva, M. A. N. d., Barreto-Vieira, D. F., . . . Miranda, M. D. Nanotechnology-Driven Strategy Against SARS-CoV-2: Pluronic F127-Based Nanomicelles with or Without Atazanavir Reduce Viral Replication in Calu-3 Cells. MDPI AG.
Chicago Style (17th ed.) CitationRicci-Junior, Eduardo, et al. Nanotechnology-Driven Strategy Against SARS-CoV-2: Pluronic F127-Based Nanomicelles with or Without Atazanavir Reduce Viral Replication in Calu-3 Cells. MDPI AG.
MLA (9th ed.) CitationRicci-Junior, Eduardo, et al. Nanotechnology-Driven Strategy Against SARS-CoV-2: Pluronic F127-Based Nanomicelles with or Without Atazanavir Reduce Viral Replication in Calu-3 Cells. MDPI AG.
Warning: These citations may not always be 100% accurate.